0001062993-24-011570.txt : 20240531
0001062993-24-011570.hdr.sgml : 20240531
20240531165735
ACCESSION NUMBER: 0001062993-24-011570
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240529
FILED AS OF DATE: 20240531
DATE AS OF CHANGE: 20240531
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SHERMAN JEFFREY W
CENTRAL INDEX KEY: 0001230482
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36510
FILM NUMBER: 241010603
MAIL ADDRESS:
STREET 1: C/O IDM PHARMA, INC.
STREET 2: 9 PARKER, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Larimar Therapeutics, Inc.
CENTRAL INDEX KEY: 0001374690
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 203857670
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: THREE BALA PLAZA EAST. SUITE 506
CITY: BALA CYNWYD
STATE: PA
ZIP: 19004
BUSINESS PHONE: 844-511-9056
MAIL ADDRESS:
STREET 1: THREE BALA PLAZA EAST. SUITE 506
CITY: BALA CYNWYD
STATE: PA
ZIP: 19004
FORMER COMPANY:
FORMER CONFORMED NAME: ZAFGEN, INC.
DATE OF NAME CHANGE: 20100301
FORMER COMPANY:
FORMER CONFORMED NAME: ZAFGEN INC
DATE OF NAME CHANGE: 20060906
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2024-05-29
0001374690
Larimar Therapeutics, Inc.
LRMR
0001230482
SHERMAN JEFFREY W
C/O LARIMAR THERAPEUTICS, INC.
THREE BALA PLAZA EAST, SUITE 506
BALA CYNWYD
PA
19004
1
0
0
0
0
Stock Option (Right to Buy)
7.07
2024-05-29
4
A
0
19000
0
A
2034-05-29
Common Stock
19000
19000
D
The options vest on the earlier of (a) May 29, 2025 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.
/s/ Jennifer Johansson, Attorney-in-fact
2024-05-31